These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29217261)

  • 1. Synucleinopathies in neurodegenerative diseases: Accomplices, an inside job and selective vulnerability.
    Azizi SA; Azizi SA
    Neurosci Lett; 2018 Apr; 672():150-152. PubMed ID: 29217261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradative organelles containing mislocalized alpha-and beta-synuclein proliferate in presenilin-1 null neurons.
    Wilson CA; Murphy DD; Giasson BI; Zhang B; Trojanowski JQ; Lee VM
    J Cell Biol; 2004 May; 165(3):335-46. PubMed ID: 15123735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress: apoptosis in neuronal injury.
    Loh KP; Huang SH; De Silva R; Tan BK; Zhu YZ
    Curr Alzheimer Res; 2006 Sep; 3(4):327-37. PubMed ID: 17017863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.
    Villar-Piqué A; Lopes da Fonseca T; Outeiro TF
    J Neurochem; 2016 Oct; 139 Suppl 1():240-255. PubMed ID: 26190401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases.
    Melki R
    J Parkinsons Dis; 2015; 5(2):217-27. PubMed ID: 25757830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases.
    Chi H; Chang HY; Sang TK
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
    Peelaerts W; Baekelandt V
    J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apoptosis in neurodegenerative diseases: facts and controversies].
    Jiménez del Rio M; Vélez-Pardo C
    Rev Neurol; 2001 May 1-15; 32(9):851-60. PubMed ID: 11424038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of laser capture microdissection in the study of neurodegenerative disease.
    Standaert DG
    Arch Neurol; 2005 Feb; 62(2):203-5. PubMed ID: 15710848
    [No Abstract]   [Full Text] [Related]  

  • 12. Proteinaceous intracellular inclusions in neurodegenerative disorders.
    Dziewulska D; Rafałowska J
    Folia Neuropathol; 2005; 43(2):51-63. PubMed ID: 16012906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton.
    Esposito A; Dohm CP; Kermer P; Bähr M; Wouters FS
    Neurobiol Dis; 2007 Jun; 26(3):521-31. PubMed ID: 17408955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroprotective role of vesicular monoamine transporter 2 in neurodegenerative diseases.
    Yulug B; Hanoglu L; Kilic E
    Med Chem; 2015; 11(2):104-8. PubMed ID: 25256242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysines, Achilles' heel in alpha-synuclein conversion to a deadly neuronal endotoxin.
    Plotegher N; Bubacco L
    Ageing Res Rev; 2016 Mar; 26():62-71. PubMed ID: 26690800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial cell death induced by overexpression of alpha-synuclein.
    Stefanova N; Klimaschewski L; Poewe W; Wenning GK; Reindl M
    J Neurosci Res; 2001 Sep; 65(5):432-8. PubMed ID: 11536327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interrelations between malfunctioning DNA damage response (DDR) and the functionality of the neuro-glio-vascular unit.
    Barzilai A
    DNA Repair (Amst); 2013 Aug; 12(8):543-57. PubMed ID: 23706773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation.
    Íñigo-Marco I; Valencia M; Larrea L; Bugallo R; Martínez-Goikoetxea M; Zuriguel I; Arrasate M
    Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8274-E8283. PubMed ID: 28900007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies.
    Prots I; Grosch J; Brazdis RM; Simmnacher K; Veber V; Havlicek S; Hannappel C; Krach F; Krumbiegel M; Schütz O; Reis A; Wrasidlo W; Galasko DR; Groemer TW; Masliah E; Schlötzer-Schrehardt U; Xiang W; Winkler J; Winner B
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):7813-7818. PubMed ID: 29991596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synphilin in normal human brains and in synucleinopathies: studies with new antibodies.
    Murray IJ; Medford MA; Guan HP; Rueter SM; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2003 Feb; 105(2):177-84. PubMed ID: 12536229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.